Volume 7 Issue 2 (March - April), 2021

Original Articles

Assessment of risk of hypertension in COVID-19 patients
Parivallal Vignesh, Roli Singh, Thangaraj Sharmiladevi, Mantri Harshika, B Suba Ranjana, Arangasamy Vinotha

Background: Cardiovascular diseases (CVDs) are known to be triggered by acute respiratory infections caused by viruses or bacteria. The presence of underlying CVD is often linked with other comorbidities that predispose patients to more frequent and severe forms of infection. The present study was conducted to assess the risk of hypertension in COVID-19 patients. Materials & Methods: 46 cases of COVID- 19 positive patients were included. Severe COVID-19 was defined as the presence of respiratory distress (respiratory distress (30 breaths or more per min), oxygen saturation of ≤93% at rest, PaO2 /FiO2 ratio of 300mm Hg) or the need for ICU care. The occurrence of hypertension and cardiovascular disease was recorded. Results: Out of 46 patients, males were 30 and females were 16. The mean age of patients was 43.6 years, mean weight was 60.2 Kgs. Hypertension was present in 20, CVDs in 25 and diabetes in 22. Out of 46 patients, 41 survived and 5 died. The difference was significant (P< 0.05). Conclusion: CVD and the associated risk factors (hypertension) were closely related to fatal outcomes in patients with COVID-19. Key words: COVID-19, Cardiovascular disease, Hypertension.

 
Abstract View | Download PDF | Current Issue